Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease
Tuulia Hyötyläinen, Livnat Jerby, Elina M. Petäjä and 7 more
Nature Communications · 2016
doi:10.1038/ncomms9994 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a risk factor for other types of liver diseases. Here, the authors integrate transcriptomic and metabolomic data from patients with NAFLD with a genome-scale metabolic model to paint a comprehensive picture of liver function in NAFLD.
Abstract licence: CC BY-NC-ND
Cited by papers we hold2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.